Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schuth Alexander O.
Relationship:   COFO and Secretary
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   187,341    

Indirect Shares

  523,749      
Direct Value   $3,883,579    

Indirect Value

  $10,857,317      
Total Shares   711,090      
Total Value   $14,740,896      


Denali Therapeutics Inc.
 $3,883,579 Denali Therapeutics Inc.
 $3,883,579
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    15    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    13    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -30.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Denali Therapeutics Inc. DNLI COFO and Secretary 2024-02-14 187,341 2024-02-14 523,749    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-01-04 4 AS $65.17 $5,246,408 I/I (70,000) 544,562 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-07-06 4 AS $76.20 $762,040 I/I (10,000) 491,582 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-02-04 4 AS $66.65 $678,361 I/I (10,000) 534,562 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-06-04 4 AS $64.35 $645,500 I/I (10,000) 501,582 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-03-04 4 AS $60.89 $610,171 I/I (10,000) 531,582 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-09-07 4 AS $54.70 $555,485 I/I (10,000) 474,038 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-05-04 4 AS $55.09 $554,864 I/I (10,000) 511,582 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-11-04 4 AS $52.65 $528,404 I/I (10,000) 463,083 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-08-04 4 AS $51.52 $522,233 I/I (10,000) 481,582 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-10-04 4 AS $50.24 $505,605 I/I (10,000) 473,083 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-12-06 4 AS $41.82 $422,736 I/I (10,000) 453,083 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-02-14 4 AS $17.66 $355,460 D/D (20,128) 187,341 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-07-17 4 AS $29.60 $296,000 I/I (10,000) 528,691 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-01-17 4 AS $29.53 $295,339 I/I (10,000) 497,173 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-07-18 4 AS $30.01 $291,157 I/I (9,702) 518,989 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-05-15 4 AS $28.55 $286,044 I/I (10,000) 528,691 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-11-25 4 AS $18.02 $254,533 I/I (14,125) 584,607 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2021-02-11 4 S $70.17 $214,341 I/I (3,047) 541,582 0 %
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2024-01-05 4 S $19.43 $193,756 I/I (9,972) 539,307 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-07-08 4 AS $20.25 $152,135 I/I (7,500) 625,089 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-08-07 4 AS $18.81 $141,075 I/I (7,500) 617,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-06-10 4 AS $18.77 $140,775 I/I (7,500) 632,589 0 -
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2019-09-09 4 AS $18.16 $136,200 I/I (7,500) 610,089 0 -
DNLI Denali Therapeutics Inc. COFO and Secretary   •       –      –    2023-04-12 4 AS $25.04 $127,754 I/I (5,102) 528,691 0 %
DNLI Denali Therapeutics Inc. COO and Secretary   •       –      –    2022-01-05 4 S $44.77 $127,415 I/I (2,846) 457,737 0 %

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed